AIM:RUA · Health Care · Medical device technology — implantable textiles, biostable polymers and cardiovascular device contract development/manufacturing and IP licensing

RUA Life Sciences plc

RUA Life Sciences plc (formerly AorTech International, registered in Scotland, company number SC170071) is a medical device group specialising in implantable textiles and biostable polymers. It develops and licenses device-related IP (notably the Elast-Eon polyurethane and AurTex composite), develops and manufactures components and finished devices under contract for customers (Medical Devices and Components, including its Abiss France/Poland subsidiaries), and is developing its own vascular graft and polymeric heart valve products. Revenue is generated through Biomaterials licensing/royalties and Contract Manufacture/Medical Devices & Components; Vascular and Structural Heart are earlier-stage development areas.

Export the RUA Life Sciences plc factsheetfree account Open the FY2025 report

Share price and financials

No price history · 11 reported years, FY2015–FY2025

No daily prices have been collected for this company.

Line	FY2015locked	FY2016locked	FY2017locked	FY2018locked	FY2019locked	FY2020locked	FY2021locked	FY2022locked
Revenue	5.3	2.1	3.7	4.8	2.7	3.9	2.1	3.7
Gross profit	2.6	2.5	4.2	3.9	3.1	3.0	2.5	2.0
Operating profit	(1.6)	(1.1)	(1.5)	(1.9)	(1.2)	(1.7)	(2.0)	(1.8)
Net finance cost	0.05	0.04	0.05	0.06	0.04	0.05	0.03	0.04
Profit before tax	(1.9)	(1.0)	(1.5)	(1.6)	(2.1)	(1.7)	(1.0)	(2.0)
Tax charge	(0.30)	(0.23)	(0.19)	(0.21)	(0.23)	(0.37)	(0.21)	(0.19)
Profit for the year	(1.7)	(1.1)	(0.80)	(1.3)	(1.1)	(1.7)	(1.2)	(0.97)
EBITDA	(1.9)	(1.8)	(1.5)	(1.6)	(1.2)	(0.93)	(1.6)	(1.1)
Basic EPS	(5.21p)	(4.77p)	(5.62p)	(6.38p)	(4.49p)	(4.07p)	(3.58p)	(3.03p)
Diluted EPS	(2.52p)	(4.73p)	(4.92p)	(6.46p)	(4.64p)	(6.47p)	(5.96p)	(6.18p)
Dividend per share	0.00p	0.00p	0.00p	0.00p	0.00p	0.00p	0.00p	0.00p

GBP millions, negatives in brackets. Per-share lines in pence. later is what a following report restated the figure to; vs is a second reading that disagrees. The figure shown is the one the original filing printed, and both readings are kept. Click any figure: opens the report page it was read from, highlighted; shows how it was calculated.

2 figures

3 years, at a glance

GBP · %

Dashed: Operating margin, in % on its own scale — read its shape, not its height against the bars.

FY2025Revenue£6.7mOperating margin−3.8%